BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 29288947)

  • 21. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies.
    Sharma P; LaRosa C; Antwi J; Govindarajan R; Werbovetz KA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial
    Ahenkorah S; Coertzen D; Tong JX; Fridianto K; Wittlin S; Birkholtz LM; Tan KSW; Lam Y; Go ML; Haynes RK
    ACS Med Chem Lett; 2020 Jan; 11(1):49-55. PubMed ID: 31938463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
    Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
    Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents.
    Han X; Luo J; Wu F; Hou X; Yan G; Zhou M; Zhang M; Pu C; Li R
    Eur J Med Chem; 2016 May; 114():232-43. PubMed ID: 26994691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
    Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
    Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents.
    Wei Q; Li J; Tang F; Yin Y; Zhao Y; Yao Q
    Eur J Med Chem; 2018 Jan; 144():504-516. PubMed ID: 29288947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photochemical synthesis, intercalation with DNA and antitumor evaluation in vitro of benzo[d]thiazolo[3,2-a]quinolin-10-ium derivatives.
    Saifutiarova AE; Fedorov YV; Tsvetkov VB; Rustamova DA; Gulakova EN; Chmelyuk NS; Abakumov MA; Aliev TM; Fedorova OA
    Bioorg Chem; 2021 Oct; 115():105267. PubMed ID: 34426158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naphthalimides as anti-cancer agents: synthesis and biological activity.
    Braña MF; Ramos A
    Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):237-55. PubMed ID: 12678756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear naphtho-gamma-pyrones: a naturally occurring scaffold of biological importance.
    Barrow RA; McCulloch MW
    Mini Rev Med Chem; 2009 Mar; 9(3):273-92. PubMed ID: 19275720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-Apoptotic Activity of Bioactive Compounds from Seaweeds: Promising Sources for Developing Novel Anticancer Drugs.
    Agena R; de Jesús Cortés-Sánchez A; Hernández-Sánchez H; Jaramillo-Flores ME
    Mar Drugs; 2023 Mar; 21(3):. PubMed ID: 36976231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terephthalamidine: past and future.
    Fisherman JS; Cline EM; Plowman J; Quinn FR; Hawkins MJ
    Invest New Drugs; 1991 Nov; 9(4):295-303. PubMed ID: 1804802
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.